SUSAN MIDILI: Open Payments
NPI 1487694774 · PENNSAUKEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 43 payments from 11 companies in 2025. Trend: 2023 $788 · 2024 $1,169 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $169 |
| AstraZeneca Pharmaceuticals LP | 10 | $165 |
| ABBVIE INC. | 2 | $110 |
| Exact Sciences Corporation | 4 | $78 |
| Lilly USA, LLC | 4 | $72 |
| Amgen Inc. | 3 | $51 |
| PFIZER INC. | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Lundbeck LLC | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: UBRELVY, FARXIGA, AIRSUPRA, Cologuard Collection Kit, Rybelsus, Wegovy, MOUNJARO, EVENITY.
Industry payments across NJ — which companies pay providers there.
